Showing 1 - 7 results of 7 for search '(((( 50 ((_ decrease) OR (mean decrease)) ) OR ( 10 mg decrease ))) OR ( 50 ms decrease ))~', query time: 1.12s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Image_1_Metyrapone Versus Osilodrostat in the Short-Term Therapy of Endogenous Cushing’s Syndrome: Results From a Single Center Cohort Study.jpg by Mario Detomas (11304897)

    Published 2022
    “…Under osilodrostat, a QTc-interval prolongation was identified at T3 (mean 432 ms vs 455 ms). From T0 to T2, the number of antihypertensive drugs remained comparable under metyrapone and decreased under osilodrostat (n= -0.3 vs n= -1.0).…”
  5. 5

    Table_1_Metyrapone Versus Osilodrostat in the Short-Term Therapy of Endogenous Cushing’s Syndrome: Results From a Single Center Cohort Study.docx by Mario Detomas (11304897)

    Published 2022
    “…Under osilodrostat, a QTc-interval prolongation was identified at T3 (mean 432 ms vs 455 ms). From T0 to T2, the number of antihypertensive drugs remained comparable under metyrapone and decreased under osilodrostat (n= -0.3 vs n= -1.0).…”
  6. 6
  7. 7